The increased mRNA and protein levels of B4GALT5 are associated with poor prognosis for hepatocellular carcinoma, ovarian cancer, cervical cancer and other cancers [32,33,34,35]. This evidence concerns the gene B4GALT5 and hepatocellular carcinoma.